You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

August 27, 2014

Registering Common Characters as Trademarks

Informed Counsel

In Thailand, the requirements for trademark registration are specified in Section 7 of the Trademark Act. One requirement, subject to certain exceptions, stipulates that marks must possess the element of “distinctiveness,” in that they must be distinguishable from the marks of other parties in the eyes of the general public (this quality is also referred to as “inherent distinctiveness”). The second paragraph of this provision states the essential elements that constitute such distinctiveness.

The second paragraph of Section 7 does not, however, explicitly provide for any restrictions on the registration of marks that consist of individual Roman letters, Arabic numerals, mathematical symbols, scientific symbols, or abbreviations. This has led to uncertainty as to whether or not those elements are deemed distinctive.

In practice, the Department of Intellectual Property (DIP) either: (i) orders such elements in marks to be disclaimed; or (ii) rejects an application for a mark consisting of such elements entirely. This approach is justified on the basis that the elements are common terms, generic, or words having general meaning.

In view of this, many applicants will disclaim such elements in their marks ahead of time to allow for the registration process to continue unhindered. An applicant whose whole mark contains such generic content runs the risk of its mark being considered unregistrable by the DIP.

In such cases, some trademark owners have challenged the decision of the DIP by initiating legal proceedings with the Central Intellectual Property and International Trade Court (IP&IT Court). The following case studies provide insight into how the Thai courts assess trademark distinctiveness in such cases.

~H2O+

In 2001, H2O Plus L.P., a well-known U.S. manufacturer of cosmetics and other body-care products, filed applications for its house brand ~H2O+, among other things, for services in Class 35 that cover business management for retail stores.

The Registrar and the Board of Trademarks, under the authority of the DIP, considered the mark ~H2O+ to be nondistinctive based on the use and inclusion of common Roman letters, Arabic numerals, and mathematical symbols in the mark. The DIP deemed the mark to be unregistrable and ordered its rejection.

H2O Plus appealed the decisions reached by the Registrar and the Board of Trademarks to the IP&IT Court, contending that the mark was neither descriptive of the services (another requirement for word marks being that they must not directly refer to the character or quality of the goods or services) nor nondistinctive, as had been claimed by the DIP.

Upon consideration, the IP&IT Court found that the mark ~H2O+ referred to the chemical formula for water and did not make a direct reference to the character or quality of the retail services in Class 35. The Court, therefore, considered the DIP’s order to be unlawful and allowed the mark ~H2O+ to be registered for the services in Class 35. The Court’s judgment was affirmed by the Supreme Court in 2007, which provided that, given the services covered by the mark, ~H2O+ was an inherently distinctive mark, because the mark made no direct reference to the character or quality of the services.

4°C

A recent Supreme Court judgment, issued in 2014, mirrors the same principle followed by the IP&IT Court and Supreme Court in the H2O Plus case.

In 2005, ASTY Inc., a Japanese company, filed applications to register the mark 4°C for products in Classes 14, 18, and 25 in Thailand. The Registrar and the Board of Trademarks rejected the applications, considering the mark 4°C to be nondistinctive due to the use and inclusion of common mathematical symbols and the common abbreviations for degrees Celsius. ASTY Inc. appealed the decision to the IP&IT Court.

The IP&IT Court declared that fanciful marks, arbitrary marks, or suggestive marks are considered to possess the element of distinctiveness. The provisions of the Trademark Act do not stipulate that a generic word or a word having general meaning cannot be distinctive. The IP&IT Court therefore accepted the registration of the mark 4°C.

The DIP, as the defendant, appealed the IP&IT Court’s judgment to the Supreme Court. In 2014, the Supreme Court ruled that the plaintiff’s trademark 4°C was distinctive under Section 7 of the Trademark Act. The Supreme Court further elaborated that “a distinctive trademark” is one which enables the public or users to distinguish the goods with which the trademark is used from other goods.

The Supreme Court also held that the provisions of the Trademark Act do not stipulate that a generic word or a word having general meaning cannot be distinctive. Although the plaintiff’s trademark 4°C was composed of the number “4,” the symbol “°,” and the letter “C” as an abbreviation of degrees Celsius, the combination of which refer to the general meaning of “4 degrees Celsius,” the trademark had no direct reference to the character or quality of goods specified under the applications; for instance, metalware used on a dining table (International Class 14), briefcases (International Class 18), and bathing suits (International Class 25). Hence, the plaintiff’s trademark 4°C was inherently distinctive, and thus registrable.

Flexible View by the Courts

These two judgments evidence the fact that the courts have a broader, more flexible view in considering the distinctiveness of trademarks. Individual Roman letters, Arabic numerals, mathematical symbols, scientific symbols, abbreviations, or any combination of these elements may be accepted for registration and considered distinctive, as long as they do not directly reference the character or quality of the goods or services specified in the applications.

RELATED INSIGHTS​ 

July 6, 2026
Indonesia’s regulation on reporting online intellectual property (IP) infringement provides comprehensive procedural guidance for IP rights holders and their licensees in reporting online infringement complaints. Issued in December 2025 by the Ministry of Law as Regulation No. 47 of 2025 regarding Handling of Intellectual Property Infringement Reports in Electronic Systems, this regulation covers all types of IP rights. It also specifies documentation when reporting infringement, and lays out the procedures for examination, verification, and enforcement actions. Submission of Complaints Complainants may submit reports through the online system of the Directorate General of Intellectual Property (DGIP) or in person at the DGIP office. Complaints may also be filed through an authorized proxy. Under the regulation, complainants are required to provide the following information and documents: Personal details of the complainant; Brief description of the protected work or subject matter (i.e., type of IP and name or address of the infringing website, portal, account, or application, or a link to the location of the infringing content); Complete description of the alleged infringement; Certificate of registration or recordal of the relevant IP; Recordal of IP license agreement, if any; and Other supporting evidence. Verification and Examination Process Upon receiving a complaint, the responsible formality officer may request clarification or additional supporting documents. In the latter case, the complainant must then submit the necessary administrative documents within 14 days of the notification date. Once the documentation is deemed complete and sufficient, the case will be formally registered. Subsequently, the DGIP will establish a verification team to handle online IP violations, which will include the Civil Servant Investigator (PPNS), the Ministry of Communication and Digital Affairs, experts with relevant expertise in IP, and representatives from related associations such as AVISI (Indonesian Video Streaming Association). After examining the report, the team will prepare the Minutes
June 30, 2026
Customs recordation is an enforcement mechanism in Myanmar that enables intellectual property (IP) rights holders to seek prevention of the cross-border movement of infringing goods. The enactment of Myanmar’s IP laws in 2019 has enabled customs recordation for registered marks and copyrights under the Trademark Law 2019 and the Copyright Law 2019. By contrast, the Patent Law 2019 and the Industrial Design Law 2019 do not provide a practical framework for customs recordation, and accordingly such rights are not subject to the customs recordation regime. Under the Trademark Law 2019, rights holders may apply for customs recordation and may also ask the Customs Department to suspend the release of goods suspected of bearing counterfeit marks. Likewise, the Copyright Law 2019 allows for customs intervention in relation to pirated works. These provisions reflect Myanmar’s gradual alignment with international standards on border measures, although the implementation framework remains at a relatively early stage of development. Customs Recordation Pursuant to the Trademark Law 2019 and the Copyright Law 2019, the relevant authorities have issued customs rules concerning the protection of registered marks and copyrights. In practice, the process generally begins with the submission of an application to the Customs Department together with supporting documentation. This typically includes proof of registration in Myanmar; details of the rights holder, applicant, and any authorized representative; and a comprehensive description of the genuine goods. Product identification materials—such as photographs, packaging samples, and distinguishing features—are particularly important in helping customs officers identify suspected infringing goods. A recordation remains valid for two years from the date of approval. It may be renewed for additional two-year terms, provided that the renewal application is filed within the thirty days prior to expiry for marks and up to thirty days in advance of the expiry date for copyrights, in accordance with
June 29, 2026
Thailand’s cabinet has approved the draft Act on Liability for Defective Goods, commonly called Thailand’s “Lemon Law.” The Draft Act is currently pending consideration by Parliament. The draft law aims to strengthen buyers’ position in pursuing cases against sellers. While the Civil and Commercial Code offers provisions governing liability for defective goods, it is difficult in practice for buyers to successfully make a claim against sellers, particularly where defects are latent and not discoverable at the time of sale or delivery. By introducing product-specific rules and clearer remedies, the new law is intended to modernize Thailand’s consumer protection framework and align it more closely with international standards, and to help relieve the buyer’s burden of proof against the seller in product liability cases. If enacted, the draft act will take effect 180 days after publication in the Government Gazette, giving businesses a transition period to assess their compliance obligations. This article provides an overview of the key provisions of the draft act and highlights some practical considerations for businesses operating in Thailand. Scope and Key Definitions The draft act applies to sellers—defined as persons who sell goods in the ordinary course of business—and protects buyers, a term defined broadly to include not just the original purchaser but also transferees and successors in title. This expands the class of people who can bring claims. The law does not apply to used goods, live animals, or goods exempted by future ministerial regulation. It also leaves intact any separate warranties, promises, advertisements, or other guarantees a seller has given; those remain enforceable alongside the new statutory rights. General Liability for Defective Goods Sellers are liable for defects that exist at the time of delivery, regardless of whether the seller knew about them. Liability arises where a defect reduces: The benefit intended under
June 24, 2026
Patent enablement requirements are provided under Article 102 of Vietnam’s Law on Intellectual Property (IP Law). In particular, a patent specification must “fully and clearly disclose the nature of the invention to such an extent that, based on the specification, a person having ordinary skill in the relevant art can implement the invention.” In pharmaceutical and biotechnology patents, this requirement is more complicated and subject to more rigorous assessment. The Patent Examination Guidelines (Guidelines) of the Intellectual Property Office of Vietnam (IP Office) were amended in March 2026 to introduce Annexes III and IV for the pharmaceutical and biotechnology sectors, in which Annex III provides detailed guidelines on the assessment of specification requirements. These amendments were made under a project for strengthening capacity in industrial property examination between the Japan International Cooperation Agency (JICA) and the IP Office. Annex III provides detailed instructions on how examiners assess enablement in a pharmaceutical or biotechnology application, and offers examples of acceptable and unacceptable descriptions with regard to the enablement aspect. Enablement Requirements in Pharma and Biotech Patents Article 12.7 of Circular 10/2026/TT-BKHCN (Circular 10) adds to the requirements of Article 102 of the IP Law that the description must demonstrate the novelty, inventive step, and industrial applicability of the technical solution. For pharmaceutical composition subject matters, Article 12.9 of Circular 10 sets out that the description must present the results of clinical trials and/or the pharmacological effects of the claimed pharmaceutical composition, and must include at least the following information: Substance/mixture used. Testing method (system) employed. Information on the test results. Correlation between the pharmacological effects obtained from the tests and the application of the pharmaceutical product in the prevention, diagnosis, and treatment of diseases. The Guidelines note that pharmacological study results should be presented in a quantified manner, and pharmacological